Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04053322
Brief Title: Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients. (DOLAF)

First Submitted : August 9, 2019
First Submitted that Met QC Criteria : August 9, 2019
First Posted : August 12, 2019

Last Update Submitted that Met QC Criteria : November 5, 2021
Last Update Posted : November 8, 2021